Blocking CD38 in vivo in a mouse model of lung cancer led to a significant reduction of the total Treg cell population within the TME [24], potentially due to expression of CD38 on these cells and/or occurring through NAD+ accumulation and Treg cell death. This evidence concerns the gene CD38 and lung carcinoma.